Dr. Robert Eugene Van Demark III, MD

Dr. Van Demark practices at Sanford Medical Center - Unit in Sioux Falls, South Dakota.

Dr. Van Demark's NPI, 1063708915, was assigned on June 20, 2011. Dr. Van Demark graduated from Creighton University School of Medicine in 2011. Dr. Van Demark holds South Dakota license 10520.

Dr. Van Demark's primary practice is Sanford Medical Center - Unit, at 1305 W 18th Street, Sioux Falls, SD 57117 in Minnehaha County. The practice phone is (605) 328-6758.

Dr. Van Demark's primary practice is Sanford Medical Center - Unit in Sioux Falls, South Dakota. Dr. Van Demark is also affiliated with Sanford USD Medical Center. The medical group on file is Edith Sanford Breast Center Sioux Falls. Dmand AI also links Dr. Van Demark to 3 more hospitals, 2 group practices and clinics, 1 imaging center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Van Demark practices, 8 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Van Demark's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dmand AI has Dr. Van Demark's licenses on file in 3 states: South Dakota, Minnesota and North Carolina.

CMS data shows 165 Medicare services from Dr. Van Demark across 4 procedure codes in 2024, for 147 Medicare patients. Medicare paid $33,288 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 147 Medicare patients who saw Dr. Van Demark in 2024. The largest group is 65 to 74, with 49 patients. 75% of them have arthritis, and 75% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Van Demark's median patient age at 73, with 55% women.

In 2023, Dr. Van Demark wrote 13 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $92 in total drug cost. In 2022, CMS named 15 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Van Demark for performance year 2024, reported as part of a group. Dr. Van Demark accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Van Demark, published from 2015 to 2019. The most frequent topics are Reoperation, Arthroplasty, Replacement, Hip and Hip Prosthesis. Dr. Van Demark's most frequent co-authors are Robert T. Trousdale, MD, Steven L. Moran, MD and Rafael J. Sierra, MD.

CMS Open Payments shows 27 general payments to Dr. Van Demark from 9 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 53% of the total. Stryker Corporation paid the most, $1,121.

Dr. Van Demark graduated from Creighton University School of Medicine in 2011.